Imprinted Expression of SNRPN in Human Preimplantation Embryos  by Huntriss, John et al.
Am. J. Hum. Genet. 63:1009–1014, 1998
1009
Imprinted Expression of SNRPN in Human Preimplantation Embryos
John Huntriss,1 Robert Daniels,1 Virginia Bolton,2 and Marilyn Monk1
1Molecular Embryology Unit, Institute of Child Health, and 2King’s Assisted Conception Unit, Department of Obstetrics and Gynaecology,
King’s College, London
Summary
Prader-Willi syndrome (PWS) and Angelman syndrome
(AS) are two clinically distinct neurogenetic disorders
arising from a loss of expression of imprinted genes
within the human chromosome region 15q11-q13. Re-
cent evidence suggests that the SNRPN gene, which is
defective in PWS, plays a central role in the imprinting-
center regulation of the PWS/AS region. To increase our
understanding of the regulation of expression of this
imprinted gene, we have developed single-cell–sensitive
procedures for the analysis of expression of the SNRPN
gene during early human development. Transcripts of
SNRPNwere detected in human oocytes and at all stages
of preimplantation development analyzed. Using em-
bryos heterozygous for a polymorphism within the
SNRPN gene, we showed that monoallelic expression
from the paternal allele occurs by the 4-cell stage. Thus,
the imprinting epigenetic information inherited in the
gametes is recognized already in the preimplantation em-
bryo. The demonstration of monoallelic expression in
embryos means that efficient preimplantation diagnosis
of PWS may be made by analysis for the presence or
absence of SNRPN mRNA.
Introduction
The SNRPN gene encodes SmN, a 29-kD spliceosomal
protein associated with small nuclear ribonucleoprotein
particles. It is expressed predominantly in brain and
heart (McAllister et al. 1988), and expression is im-
printed in human and mouse, with only the paternal
allele being transcribed in somatic tissues (Cattanach et
al. 1992; Leff et al. 1992; Reed and Leff 1994). The
human SNRPN gene maps to the smallest deletion re-
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gion associated with a neurological disorder, Prader-
Willi syndrome (PWS), thus implicating the involvement
of SNRPN (Leff et al. 1992). The disease phenotype is
associated with paternal deletions or maternal unipar-
ental disomy in the chromosome region 15q11-q13 (for
a review, see Glenn et al. 1997). Further PWS cases are
caused by disruption of the imprinting center upstream
from the SNRPN transcription-start site (Buiting et al.
1995); alternative transcripts of the SNRPN gene are
believed to be critical in resetting the correct epigenetic
information on the imprinted genes within the PWS/AS
region during gametogenesis (Dittrich et al. 1996).
During the early stages of mouse development, there
is variation in the time of establishment of monoallelic
expression of different imprinted genes. Monoallelic ex-
pression from the paternal allele of Snrpn is observed in
the mouse, from the 4-cell stage onward (Szabo and
Mann 1995). Similarly, expression of the mouse im-
printed U2afbp-rs gene is monoallelic from the paternal
allele in 2-cell–stage preimplantation embryos (Latham
et al. 1995). In contrast, biallelic expression of the im-
printed Igf2r gene occurs at all stages of mouse preim-
plantation development (Szabo and Mann 1995), and
the switch to monoallelic maternal expression occurs
near the time of implantation (Lerchner and Barlow
1997). These data suggest that the differential epigenetic
information inherited from the gametes and involved in
the process of establishment of monoallelic expression
for the imprinted genes exerts its effect at different stages
during early development. Therefore, the mechanisms
involved in the recognition of imprinting modifications
may be diverse. In this work we have determined
whether monoallelic SNRPN expression occurs during
human preimplantation embryonic development.
Material and Methods
Human Samples
Sperm.—Anonymized sperm samples were provided
by the Assisted Conception Unit, King’s College Hos-
pital, London (ACU). Sperm samples were washed in
PBS, and groups of ∼50 sperm were isolated in droplets
of PBS under oil, by means of finely pulled glass pipettes.
Follicle cells.—Anonymized follicle cells, obtained,
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with consent, from patients attending the ACU were
centrifuged briefly at 12,000 g, and samples containing
∼50 cells were isolated in droplets of PBS under oil.
Oocytes.—Oocytes that had failed to be fertilized af-
ter in vitro fertilization (IVF) treatment were donated by
patients attending the ACU and were anonymized at the
source. Oocytes were scored as being unfertilized if a
male pronucleus did not form 24 h after the IVF treat-
ment. Zonae pellucidae were removed, in the manner
described for the embryos (see below).
Preimplantation embryos.—Anonymized embryos de-
rived from IVF and considered to be unsuitable for trans-
fer were isolated, and the zona pellucida of each was
removed by treatment with acid Tyrode’s solution (pH
2.0–2.4; Sigma) under oil. Care was taken to ensure
removal of all maternal cumulus cells and paternal sperm
from each embryo.
Fibroblasts and lymphocytes.—Fibroblasts were ob-
tained from J. Rainer (Institute of Child Health) and
were isolated in PBS by means of finely pulled glass
pipettes. Lymphocytes derived from thumb-prick sam-
ples were isolated, by means of a lymphocyte-separation
medium (ICN), into aliquots containing ∼50 cells.
Sample preparation for genomic PCR.—Prior genomic
PCR of the SNRPN gene in parental sperm and follicle
cells was performed to distinguish parental alleles by
means of a common polymorphism in exon 2 (Giacalone
and Francke 1994). Samples (0.5 ml) containing ∼50 cells
were added to 1.5 ml lysis buffer (1 ml proteinase K [125
mg/ml], 0.5 ml SDS [4#104% {w/v}]), were centrifuged
briefly at 12,000 g, and were overlaid with 1 drop of
mineral oil (Sigma). The cells were lysed during incu-
bation at 37C for 1 h, followed by inactivation, at 98C
for 15 min, of the proteinase K activity.
Sample preparation for RT-PCR.—Oocytes, embryos,
lymphocytes, and fibroblasts were added to 1.5 ml lysis
buffer (5 mM DTT [Sigma], 1 U RNAsin [Boehringer]/
ml, 0.8% IGEPAL [Sigma]), were centrifuged briefly at
12,000 g, were overlaid with 1 drop of mineral oil
(Sigma) and were stored at70C. Prior to reverse tran-
scription (RT), samples were held at 80C for 5 min and
then immediately were transferred to ice.
Reverse Transcription
RT was performed on samples (previously lysed in 1.5
ml RT lysis buffer) in a total volume of 5 ml comprising
the cell lysates and 40 U SuperScript II reverse tran-
scriptase (GibcoBRL), 0.9 mM of each deoxynucleotide
(Pharmacia), 2.25 mg random hexamers (BRL), 5 mM
DTT (BRL), and 2 U RNAsin (Boerhinger). Negative
controls, from which reverse transcriptase or added sam-
ple were omitted, were included.
PCR Amplification
For SNRPN expression analysis in oocytes and preim-
plantation embryos, first-round PCRs were performed
with primers S3 and S4 (fig. 1), with 2.5 units AmpliTaq
DNA polymerase (Perkin-Elmer) in 10 mM Tris-HCl pH
8.3 containing 50 mM KCl, 1.5 mM MgCl2, 0.001%
gelatin in a total volume of 25 ml (two cycles of 93C
for 5 min, 60C for 1 min, and 73C for 2 min, followed
by 30 cycles of 93C 1 min, 60C for 1 min, and 73C
for 2 min). One microliter of first-round PCR product
was then transferred to 24 ml reaction mixture, for the
second-round amplification, under the same conditions,
except for the substitution of primers S1 and S2 (fig. 1).
Products were analyzed on a 2% NuSieve/2% agarose
gel in buffer (90 min at 120 V).1# Tris-borate EDTA
Primer sequences were as follows: S1, 5′-TAC CAG CTG
GTG TGC CAA TT-3′; S2, 5′-CTC TTC CCT GTG GAG
TCA TT-3′; S3, 5′-TTG GTA GGG CAG CTG GTA GA-
3′; and S4, 5′-ACA GCA GCA GCT GCT ACA GT-3′.
For identification of embryos heterozygous for the
BstUI restriction-enzyme–site polymorphism in the
SNRPN gene, 12 sets of parental sperm and follicle sam-
ples were initially screened utilizing an SDS/ proteinase
K–treated sample in the first-round amplification. PCR
was performed as described above, with primers N1 and
N4 substituted for the first-round PCR and with primers
N5 and N6 substituted for the second-round PCR, for
these parental samples (see fig. 3). Genomic PCR prod-
ucts were digested with 10 units BstUI enzyme () (New
England Biolabs) at 60C overnight, and the products
were electrophoresed on 2% NuSieve agarose gels (90
min at 120 V), to identify parents homozygous for the
opposite alleles. Oocytes and embryos from informative
couples were then analyzed for monoallelic SNRPN ex-
pression, by use of primers N2 and N5 (spanning the
intron; see fig. 3) for the second-round RT-PCR and by
BstUI enzyme treatment of RT-PCR products, as de-
scribed above. Control reactions for BstUI digestion fol-
lowing RT-PCR were performed on fibroblasts treated
in the same fashion. Primer sequences were as follows:
N1, 5′-GCT CCA TCT ACT CTT TGA AGC-3′; N2, 5′-
CTT GCT ACT CTT GCC AAC AGT-3′; N4, 5′-GGC
CAT CTT GCA GGA TAC ATC-3′; N5, 5′-GCC CAG
CTT GCA TTG TTA CTA-3′; and N6, 5′-CAC CAA
ATC CAA TGT CCA CAG-3′.
Results
Single-cell–sensitive procedures for the detection of
SNRPN transcripts were developed using human lym-
phocytes and fibroblasts and then were applied to dem-
onstrate SNRPN expression in human preimplantation
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Figure 1 RT-PCR of the exon 5/exon 6 region of the human SNRPN gene. a, Scheme of SNRPN gene and primers used for SNRPN
expression analysis by RT-PCR. Rectangles represent exons, and arrows represent primers. b, Results for two samples of human lymphocytes
(lanes L) (∼50 lymphocytes isolated from thumb-prick samples), three single fibroblast cells (lanes f), an oocyte (lane Oo), and 1-cell–stage (lane
1C) and 4-cell–stage (lane 4C) preimplantation embryos. SNRPN transcription was observed with a high degree of efficiency in all four oocytes
tested and at all stages of preimplantation development (at the 1-cell to 8-cell stage, in 10 of 11 embryos). A control, in which RT has not
been performed, is shown in lane (-). PCR products were verified by sequencing.
embryos (fig. 1). SNRPN transcripts analyzed by RT-
PCR were detected, with a high degree of efficiency, in
unfertilized oocytes (in all four samples analyzed), and
at all stages of preimplantation development in embryos
(at the 1-cell to 8-cell stage, in 10 of 11 analyzed).
The presence of SNRPN transcripts in unfertilized ma-
ture oocytes probably is due to the earlier activity of the
SNRPN alleles during oogenesis, since we expect the
maternal allele (inherited as a silent allele) to be inactive
in mature oocytes. To determine whether this was the
case, we analyzed SNRPN transcripts in unfertilized oo-
cytes heterozygous for a BstUI polymorphism in exon 2
of the SNRPN gene (Giacalone and Francke 1994). The
scheme for the PCR reactions for RT-PCR and genomic
PCR, and the BstUI digestion to show the two alleles,
is given in figure 3a.Figure 2 shows the results of RT-
PCR analysis of SNRPN expression from oocytes from
two patients heterozygous (fig. 2a and b) for the poly-
morphism. In each case, the SNRPN transcripts are de-
rived from both parental alleles, strongly suggesting that
the transcription had occurred at an earlier time during
oogenesis, when the imprint on the maternal allele had
been erased. The presence of transcripts in the unfertil-
ized mature oocytes therefore appears to be due to earlier
transcription during oogenesis.
To determine both the onset of zygotic gene transcrip-
tion and whether preferential paternal allele expression
occurs in preimplantation embryos, we used the same
BstUI restriction-site polymorphism to distinguish the
transcripts from maternal and paternal alleles in em-
bryos. Prior to the embryo analysis, parental samples
(follicle cells and sperm) from the ACU were screened
by nested PCR and subsequent digestion with the BstUI
enzyme, to determine polymorphic alleles in the parents
and thus to predict informative heterozygous embryos.
SNRPN expression then was assessed in single hetero-
zygous 4-cell–stage preimplantation embryos, by RT-
PCR analysis followed by digestion of PCR products by
BstUI. Figure 3b shows that SNRPN expression is mon-
oallelic and expressed only from the paternal allele in
these embryos. The absence of maternally inherited tran-
scripts in the embryos also shows that the SNRPN tran-
scripts present in the unfertilized oocyte are degraded by
the time that the embryo reaches the 4-cell stage. It re-
mains possible that monoallelic expression of SNRPN
is initiated earlier, at the 2-cell stage, although, because
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Figure 2 SNRPN transcripts in human unfertilized oocytes from two women heterozygous for the BstUI polymorphism; the scheme for
the PCR reactions for RT-PCR and genomic PCR, and BstUI digestion, is shown in fig. 3a. a, Results for patient 1. The RT-PCR product and
BstUI digestion products from six pooled oocytes from patient 1 are shown in the two lanes Oo(RT), together with the genomic PCR product
and BstUI digestion products that were derived from a separate batch of six pooled oocytes from the same patient, which are shown in the
two lanes Oo(Genomic). The products are compared with BstUI-treated RT-PCR products from 10 human fibroblasts derived from an individual
homozygous for the allele with the BstUI site, which are shown in the two lanes f1 (RT) and are included to demonstrate completion of digestion.
Controls include an RTase-negative sample (lane RT-) and blanks without added sample (the two lanes PCR-) for both RT-PCR (lane RT) and
genomic PCR (lane G). The sizes of the major digestion products from the genomic PCR and RT-PCR are indicated to the right of the figure.
b, Results for patient 2. RT-PCR products and BstUI digestion products from six pooled oocytes from patient 2 are shown in the two lanes
Oo(RT), and genomic PCR products and digestion products are shown in the two lanes Oo(Genomic). Results for a control are shown in lane
f1 (RT), and results for blanks lacking RT or lacking sample are shown in lane RT- and the two lanes PCR-, respectively.
of the unavailability of earlier-stage embryos, we have
not been able to demonstrate this.
Discussion
We have developed techniques for the analysis of al-
lele-specific transcription of the SNRPN gene in human
preimplantation embryos. Transcripts of SNRPN were
detected in individual oocytes and at all stages of preim-
plantation development that were analyzed. Using a
polymorphism in the SNRPN gene, we have shown that
transcripts from both parental alleles are present in un-
fertilized oocytes, probably because of transcription at
an earlier stage of oogenesis, when the inherited mater-
nal imprint had been erased. Similar results have been
demonstrated, elsewhere, for the mouse Snrpn gene
(Szabo and Mann 1995). We have shown that maternal
transcripts in the human egg cytoplasm have been de-
graded by the time that the embryo reaches the 4-cell
stage, whenever expression is monoallelic from the pa-
ternally inherited allele.
Therefore, as is true for the mouse Snrpn gene, the
epigenetic information necessary for establishing the
monoallelic expression of human SNRPN is recog-
nized—and exerts its effect—in preimplantation em-
bryos; that is, the differential gametic epigenetic modi-
fications present on the SNRPN alleles in sperm and egg
are themselves likely to be part of the mechanism that
regulates transcription. In agreement with this, a differ-
ential methylation pattern of the 5′ region of the mouse
Snrpn gene (methylated maternal allele) is established
prior to fertilization (Shemer et al. 1997). Furthermore,
both the demonstration that methylation of the 5′ region
of the human SNRPN gene abolishes promoter activity
(Huq et al. 1997) and the observation of elevated Snrpn
mRNA levels in DNA methyltransferase-deficient mice
(Shemer et al. 1997) suggest a mechanism whereby such
a gametic methylation imprint may lead to silencing of
the maternal allele in the preimplantation embryo. In-
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Figure 3 RT-PCR of the exon 2/exon 3 polymorphic region of the human SNRPN gene. a, Scheme of SNRPN gene and primer arrangements
used for nested PCR protocols to distinguish maternal and paternal alleles. The asterisk (*) represents the polymorphism disrupting the BstUI
site, and the restriction fragments produced from RT-PCR (RT RF) and genomic PCR (Genomic RF) products are indicated. b, Results for an
informative couple in which each partner homozygous for the opposite polymorphic allele was identified by genomic PCR of sperm and follicle
cells are shown (the two lanes Pat [which show results for the father] and the two lanes Mat [which show results for the mother]). The SNRPN
RT-PCR products and BstUI digestion products (lanes ) from two 4-cell–stage embryos from these parents, which, in both cases, were found
to be of paternal origin, are shown in the two lanes 4C (a) and the two lanes 4C (b); despite the clear demonstration of SNRPN expression
in unfertilized oocytes (lane Oo), there is no evidence for the presence of maternal SNRPN transcripts in either 4-cell–stage embryo. Controls
include an RTase-negative sample (lane RT-) and blanks (the two lanes PCR-), for both the RT-PCR reaction (lane RT) and the genomic PCR
reaction (lane G). The products are compared with BstUI-treated RT-PCR products from single human fibroblasts (the two lanes f1 and the
two lanes f2) from individuals homozygous for opposite polymorphic alleles, which are included to demonstrate completion of digestion. PCR
products are compared with a 1-kb marker ladder (GibcoBRL) (lane M).
terestingly, the human IGF2 gene has been shown to be
parentally imprinted in human preimplantation em-
bryos. However, in this case, maternal IGF2 transcripts
derived from the oocyte are observed in 4-cell–stage em-
bryos, and monoallelic expression, from the paternal
allele, is first observed in the 8-cell–stage embryo
(Lighten et al. 1997). Thus, there appear to be differ-
ences between human imprinted genes, with respect to
both the time of onset of imprinted gene expression and
the stability of the maternally derived transcripts of these
genes.
Elsewhere, PWS diagnosis on the basis of the absence
of SNRPN expression in blood leukocytes has been
shown to be reliable, regardless of the underlying mu-
tation (Wevrick and Francke 1996). Our sensitive RT-
PCR assay extends this diagnostic approach to small
samples (e.g., thumb-prick samples). Moreover, our
demonstration of monoallelic SNRPN expression at the
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4-cell stage, as well as the absence of maternal transcripts
derived from the oocyte at this stage, shows that either
of the single-cell–sensitive RT-PCR procedures that we
have described for SNRPN transcripts may be applied
for accurate, reliable, preimplantation diagnosis of PWS
cases in which SNRPN is disrupted.
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